Gastroparesis: Current Diagnostic Challenges and Management Considerations

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2008 Dec 31

PMID 19115465

Citations 53

Authors

Shamaila Waseem

Baharak Moshiree

Peter V Draganov

Affiliations

Soon will be listed here.

Abstract

Gastroparesis refers to abnormal gastric motility characterized by delayed gastric emptying in the absence of mechanical obstruction. The most common etiologies include diabetes, post-surgical and idiopathic. The most common symptoms are nausea, vomiting and epigastric pain. Gastroparesis is estimated to affect 4% of the population and symptomatology may range from little effect on daily activity to severe disability and frequent hospitalizations. The gold standard of diagnosis is solid meal gastric scintigraphy. Treatment is multimodal and includes dietary modification, prokinetic and anti-emetic medications, and surgical interventions. New advances in drug therapy, and gastric electrical stimulation techniques have been introduced and might provide new hope to patients with refractory gastroparesis. In this comprehensive review, we discuss gastroparesis with emphasis on the latest developments; from the perspective of the practicing clinician.

Citing Articles

A machine learning approach to stratify patients with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders according to disorders of gut brain interaction, comorbidities and quality of life.

Choudhary A, Fikree A, Ruffle J, Takahashi K, Palsson O, Aziz I Neurogastroenterol Motil. 2024; 37(1):e14957.

PMID: 39543811 PMC: 11650402. DOI: 10.1111/nmo.14957.

Prokinetic effect of erythromycin in the management of gastroparesis in critically ill patients-our experience and literature review.

Szczupak M, Jankowska M, Jankowski B, Wierzchowska J, Kobak J, Szczupak P Front Med (Lausanne). 2024; 11:1440992.

PMID: 39314225 PMC: 11416996. DOI: 10.3389/fmed.2024.1440992.

Cross-sectional imaging after pancreatic surgery: The dialogue between the radiologist and the surgeon.

Maino C, Cereda M, Franco P, Boraschi P, Cannella R, Gianotti L Eur J Radiol Open. 2024; 12:100544.

PMID: 38304573 PMC: 10831502. DOI: 10.1016/j.ejro.2023.100544.

Treatment Challenges in the Management of Gastroparesis-Related GERD.

Fass R, McCallum R, Parkman H Gastroenterol Hepatol (N Y). 2023; 5(10 Suppl 18):4-16.

PMID: 37967396 PMC: 2886367.

Diabetic Gastroparesis and its Emerging Therapeutic Options: A Narrative Review of the Literature.

Zahid S, Tated R, Mathew M, Rajkumar D, Karnik S, Pramod Roy A Cureus. 2023; 15(9):e44870.

PMID: 37814758 PMC: 10560130. DOI: 10.7759/cureus.44870.

References

Ziegler D, Schadewaldt P, Pour Mirza A, Piolot R, Schommartz B, Reinhardt M . [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia. 1996; 39(7):823-30. DOI: 10.1007/s001250050516. View

Ghoos Y, Maes B, Geypens B, Mys G, Hiele M, Rutgeerts P . Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993; 104(6):1640-7. DOI: 10.1016/0016-5085(93)90640-x. View

McCallum R, Fink S, Lerner E, Berkowitz D . Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology. 1983; 84(6):1573-7. View

Lata P, Walbrandt Pigarelli D . Chronic metoclopramide therapy for diabetic gastroparesis. Ann Pharmacother. 2002; 37(1):122-6. DOI: 10.1345/aph.1C118. View

Friedenberg F, Palit A, Parkman H, Hanlon A, Nelson D . Botulinum toxin A for the treatment of delayed gastric emptying. Am J Gastroenterol. 2007; 103(2):416-23. DOI: 10.1111/j.1572-0241.2007.01676.x. View

Gupta Y, Sharma M . Reversal of pyrogallol-induced delay in gastric emptying in rats by ginger (Zingiber officinale). Methods Find Exp Clin Pharmacol. 2002; 23(9):501-3. DOI: 10.1358/mf.2001.23.9.662137. View

Arts J, Van Gool S, Caenepeel P, Verbeke K, Janssens J, Tack J . Influence of intrapyloric botulinum toxin injection on gastric emptying and meal-related symptoms in gastroparesis patients. Aliment Pharmacol Ther. 2006; 24(4):661-7. DOI: 10.1111/j.1365-2036.2006.03019.x. View

Kuo B, McCallum R, Koch K, Sitrin M, Wo J, Chey W . Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther. 2007; 27(2):186-96. DOI: 10.1111/j.1365-2036.2007.03564.x. View

Richards R, Davenport K, McCallum R . The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol. 1993; 88(2):203-7. View

10.

Tack J, Broekaert D, Coulie B, Fischler B, Janssens J . Influence of the selective serotonin re-uptake inhibitor, paroxetine, on gastric sensorimotor function in humans. Aliment Pharmacol Ther. 2003; 17(4):603-8. DOI: 10.1046/j.1365-2036.2003.01469.x. View

11.

Arts J, Holvoet L, Caenepeel P, Bisschops R, Sifrim D, Verbeke K . Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis. Aliment Pharmacol Ther. 2007; 26(9):1251-8. DOI: 10.1111/j.1365-2036.2007.03467.x. View

12.

Abell T, Van Cutsem E, Abrahamsson H, Huizinga J, Konturek J, Paul Galmiche J . Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion. 2003; 66(4):204-12. DOI: 10.1159/000068359. View

13.

Malagelada J, Rees W, Mazzotta L, Go V . Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology. 1980; 78(2):286-93. View

14.

Murat A, Pouliquen B, Cantarovich D, Lucas B, Bizais Y, Vecchierini M . Gastric emptying improvement after simultaneous segmental pancreas and kidney transplantation. Transplant Proc. 1992; 24(3):855. View

15.

Sturm A, Holtmann G, Goebell H, Gerken G . Prokinetics in patients with gastroparesis: a systematic analysis. Digestion. 1999; 60(5):422-7. DOI: 10.1159/000007687. View

16.

Quigley E, Hasler W, Parkman H . AGA technical review on nausea and vomiting. Gastroenterology. 2001; 120(1):263-86. DOI: 10.1053/gast.2001.20516. View

17.

Gorard D, Libby G, Farthing M . 5-Hydroxytryptamine and human small intestinal motility: effect of inhibiting 5-hydroxytryptamine reuptake. Gut. 1994; 35(4):496-500. PMC: 1374798. DOI: 10.1136/gut.35.4.496. View

18.

Mansi C, Borro P, Giacomini M, Biagini R, Mele M, Pandolfo N . Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther. 2000; 14(5):561-9. DOI: 10.1046/j.1365-2036.2000.00742.x. View

19.

Hathaway D, Abell T, Cardoso S, Hartwig M, el Gebely S, Gaber A . Improvement in autonomic and gastric function following pancreas-kidney versus kidney-alone transplantation and the correlation with quality of life. Transplantation. 1994; 57(6):816-22. DOI: 10.1097/00007890-199403270-00008. View

20.

Peeters T . Agonist effect of erythromycin and its analogues on motilin receptors. A new family of prokinetics? Clinical interest. Acta Gastroenterol Belg. 1993; 56(3-4):257-60. View